Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Ideal Cricoid Pressure Is Biomechanically Impossible During Laryngoscopy.

Trethewy CE, Doherty SR, Burrows JM, Clausen D.

Acad Emerg Med. 2018 Jan;25(1):94-98. doi: 10.1111/acem.13326. Epub 2017 Nov 3.

2.

Erratum: Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.

Pender MP, Csurhes PA, Burrows JM, Burrows SR.

Clin Transl Immunology. 2017 Jun 16;6(6):e147. doi: 10.1038/cti.2017.25. eCollection 2017 Jun.

3.

Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.

Pender MP, Csurhes PA, Burrows JM, Burrows SR.

Clin Transl Immunology. 2017 Jan 20;6(1):e126. doi: 10.1038/cti.2016.87. eCollection 2017 Jan. Erratum in: Clin Transl Immunology. 2017 Jun 16;6(6):e147.

4.

T Cell Cross-Reactivity between a Highly Immunogenic EBV Epitope and a Self-Peptide Naturally Presented by HLA-B*18:01+ Cells.

Rist MJ, Hibbert KM, Croft NP, Smith C, Neller MA, Burrows JM, Miles JJ, Purcell AW, Rossjohn J, Gras S, Burrows SR.

J Immunol. 2015 May 15;194(10):4668-75. doi: 10.4049/jimmunol.1500233. Epub 2015 Apr 8.

5.

T cell epitope clustering in the highly immunogenic BZLF1 antigen of Epstein-Barr virus.

Rist MJ, Neller MA, Burrows JM, Burrows SR.

J Virol. 2015 Jan;89(1):703-12. doi: 10.1128/JVI.02642-14. Epub 2014 Oct 29.

6.

Missense single nucleotide polymorphisms in the human T cell receptor loci control variable gene usage in the T cell repertoire.

Brennan RM, Burrows JM, Elliott T, Neller MA, Gras S, Rossjohn J, Miles JJ, Burrows SR.

Br J Haematol. 2014 Jul;166(1):148-52. doi: 10.1111/bjh.12830. Epub 2014 Mar 20. No abstract available.

PMID:
24646048
7.

Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire.

Smith C, Gras S, Brennan RM, Bird NL, Valkenburg SA, Twist KA, Burrows JM, Miles JJ, Chambers D, Bell S, Campbell S, Kedzierska K, Burrows SR, Rossjohn J, Khanna R.

Sci Rep. 2014 Feb 10;4:3993. doi: 10.1038/srep03993.

8.

HLA peptide length preferences control CD8+ T cell responses.

Rist MJ, Theodossis A, Croft NP, Neller MA, Welland A, Chen Z, Sullivan LC, Burrows JM, Miles JJ, Brennan RM, Gras S, Khanna R, Brooks AG, McCluskey J, Purcell AW, Rossjohn J, Burrows SR.

J Immunol. 2013 Jul 15;191(2):561-71. doi: 10.4049/jimmunol.1300292. Epub 2013 Jun 7.

9.

High frequency of herpesvirus-specific clonotypes in the human T cell repertoire can remain stable over decades with minimal turnover.

Neller MA, Burrows JM, Rist MJ, Miles JJ, Burrows SR.

J Virol. 2013 Jan;87(1):697-700. doi: 10.1128/JVI.02180-12. Epub 2012 Oct 17.

10.
11.

The impact of a large and frequent deletion in the human TCR β locus on antiviral immunity.

Brennan RM, Petersen J, Neller MA, Miles JJ, Burrows JM, Smith C, McCluskey J, Khanna R, Rossjohn J, Burrows SR.

J Immunol. 2012 Mar 15;188(6):2742-8. doi: 10.4049/jimmunol.1102675. Epub 2012 Feb 8.

12.

Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.

Lucas RM, Ponsonby AL, Dear K, Valery P, Pender MP, Burrows JM, Burrows SR, Chapman C, Coulthard A, Dwyer DE, Dwyer T, Kilpatrick T, Lay ML, McMichael AJ, Taylor BV, van der Mei IA, Williams D.

Neurology. 2011 Jul 26;77(4):371-9. doi: 10.1212/WNL.0b013e318227062a. Epub 2011 Jul 13.

PMID:
21753179
13.

Allelic polymorphism in the T cell receptor and its impact on immune responses.

Gras S, Chen Z, Miles JJ, Liu YC, Bell MJ, Sullivan LC, Kjer-Nielsen L, Brennan RM, Burrows JM, Neller MA, Khanna R, Purcell AW, Brooks AG, McCluskey J, Rossjohn J, Burrows SR.

J Exp Med. 2010 Jul 5;207(7):1555-67. doi: 10.1084/jem.20100603. Epub 2010 Jun 21.

14.

Strains of Epstein-Barr virus infecting multiple sclerosis patients.

Brennan RM, Burrows JM, Bell MJ, Bromham L, Csurhes PA, Lenarczyk A, Sverndal J, Klintenstedt J, Pender MP, Burrows SR.

Mult Scler. 2010 Jun;16(6):643-51. doi: 10.1177/1352458510364537. Epub 2010 Mar 29.

PMID:
20350958
15.

Variable pre-transfusion patient identification practices exist in the perioperative setting.

Burrows JM, Callum JL, Belo S, Etchells E, Leeksma A.

Can J Anaesth. 2009 Dec;56(12):901-7. doi: 10.1007/s12630-009-9180-0. Epub 2009 Oct 9.

PMID:
19816751
16.

Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.

Pandi L, Kollman JM, Lopez-Lira F, Burrows JM, Riley M, Doolittle RF.

Biochemistry. 2009 Aug 4;48(30):7201-8. doi: 10.1021/bi900647g.

PMID:
19588915
17.

The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length.

Bell MJ, Burrows JM, Brennan R, Miles JJ, Tellam J, McCluskey J, Rossjohn J, Khanna R, Burrows SR.

Mol Immunol. 2009 May;46(8-9):1911-7. doi: 10.1016/j.molimm.2008.12.003. Epub 2009 Jan 20.

PMID:
19157553
18.

Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response.

Bell MJ, Brennan R, Miles JJ, Moss DJ, Burrows JM, Burrows SR.

J Infect Dis. 2008 Jun 1;197(11):1594-7. doi: 10.1086/587848.

PMID:
18419576
19.

Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition.

Burrows JM, Bell MJ, Brennan R, Miles JJ, Khanna R, Burrows SR.

Mol Immunol. 2008 Mar;45(6):1818-24. Epub 2007 Nov 5.

PMID:
17981331
20.

Predictable alphabeta T-cell receptor selection toward an HLA-B*3501-restricted human cytomegalovirus epitope.

Brennan RM, Miles JJ, Silins SL, Bell MJ, Burrows JM, Burrows SR.

J Virol. 2007 Jul;81(13):7269-73. Epub 2007 Apr 25.

21.

The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV.

Burrows JM, Wynn KK, Tynan FE, Archbold J, Miles JJ, Bell MJ, Brennan RM, Walker S, McCluskey J, Rossjohn J, Khanna R, Burrows SR.

Eur J Immunol. 2007 Apr;37(4):946-53.

22.

TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.

Miles JJ, Borg NA, Brennan RM, Tynan FE, Kjer-Nielsen L, Silins SL, Bell MJ, Burrows JM, McCluskey J, Rossjohn J, Burrows SR.

J Immunol. 2006 Nov 15;177(10):6804-14.

23.

The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.

Tynan FE, Elhassen D, Purcell AW, Burrows JM, Borg NA, Miles JJ, Williamson NA, Green KJ, Tellam J, Kjer-Nielsen L, McCluskey J, Rossjohn J, Burrows SR.

J Exp Med. 2005 Nov 7;202(9):1249-60.

24.

T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.

Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, Miles JJ, Beddoe T, Whisstock JC, Wilce MC, Silins SL, Burrows JM, Kjer-Nielsen L, Kostenko L, Purcell AW, McCluskey J, Rossjohn J.

Nat Immunol. 2005 Nov;6(11):1114-22. Epub 2005 Sep 25.

PMID:
16186824
25.

CTL recognition of a bulged viral peptide involves biased TCR selection.

Miles JJ, Elhassen D, Borg NA, Silins SL, Tynan FE, Burrows JM, Purcell AW, Kjer-Nielsen L, Rossjohn J, Burrows SR, McCluskey J.

J Immunol. 2005 Sep 15;175(6):3826-34.

26.

Contemporaneous fluctuations in T cell responses to persistent herpes virus infections.

Crough T, Burrows JM, Fazou C, Walker S, Davenport MP, Khanna R.

Eur J Immunol. 2005 Jan;35(1):139-49.

27.

Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia.

Burrows JM, Bromham L, Woolfit M, Piganeau G, Tellam J, Connolly G, Webb N, Poulsen L, Cooper L, Burrows SR, Moss DJ, Haryana SM, Ng M, Nicholls JM, Khanna R.

J Virol. 2004 Jul;78(13):7131-7.

28.

Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.

Burrows SR, Elkington RA, Miles JJ, Green KJ, Walker S, Haryana SM, Moss DJ, Dunckley H, Burrows JM, Khanna R.

J Immunol. 2003 Aug 1;171(3):1407-12.

29.
30.

Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy.

Sherritt MA, Bharadwaj M, Burrows JM, Morrison LE, Elliott SL, Davis JE, Kear LM, Slaughter RE, Bell SC, Galbraith AJ, Khanna R, Moss DJ.

Transplantation. 2003 May 15;75(9):1556-60.

PMID:
12792514
31.

Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection.

Bharadwaj M, Burrows SR, Burrows JM, Moss DJ, Catalina M, Khanna R.

Blood. 2001 Oct 15;98(8):2588-9. No abstract available.

PMID:
11665684
32.

Survey for psychrotrophic bacterial pathogens in minimally processed lettuce.

Szabo EA, Scurrah KJ, Burrows JM.

Lett Appl Microbiol. 2000 Jun;30(6):456-60.

33.
34.
36.

The role of cytotoxic T lymphocytes in the evolution of genetically stable viruses.

Khanna R, Burrows SR, Burrows JM.

Trends Microbiol. 1997 Feb;5(2):64-9. Review. No abstract available.

PMID:
9108932
37.

Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire.

Burrows SR, Silins SL, Cross SM, Peh CA, Rischmueller M, Burrows JM, Elliott SL, McCluskey J.

Eur J Immunol. 1997 Jan;27(1):178-82.

PMID:
9022015
38.

Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.

Kerr BM, Kienzle N, Burrows JM, Cross S, Silins SL, Buck M, Benson EM, Coupar B, Moss DJ, Sculley TB.

J Virol. 1996 Dec;70(12):8858-64.

39.

Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.

Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows SR, Burrows JM, Moss DJ, Argaet VP, Misko IS.

J Exp Med. 1996 Nov 1;184(5):1815-24.

40.
41.
42.
44.

Morphine tolerance offers protection from radiogenic performance deficits.

Mickley GA, Stevens KE, Burrows JM, White GA, Gibbs GL.

Radiat Res. 1983 Feb;93(2):381-7.

PMID:
6823519
45.

The child and his family.

Burrows JM.

Nurs Times. 1973 Sep 27;69(39):1266-7. No abstract available.

PMID:
4759167

Supplemental Content

Loading ...
Support Center